Form 8-K - Current report:
SEC Accession No. 0001999371-24-006367
Filing Date
2024-05-21
Accepted
2024-05-21 08:07:07
Documents
57
Period of Report
2024-05-21
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp_8k-052124.htm   iXBRL 8-K 35244
2 PRESS RELEASE, DATED MAY 21, 2024 ex99-01.htm EX-99.01 29166
3 CORPORATE PRESENTATION BY THE COMPANY FOR MAY 2024 ex99-02.htm EX-99.02 69051
7 GRAPHIC ex99-01_img01.gif GRAPHIC 2277
8 GRAPHIC ex99-02_img01.jpg GRAPHIC 184688
9 GRAPHIC ex99-02_img02.jpg GRAPHIC 244720
10 GRAPHIC ex99-02_img03.jpg GRAPHIC 179530
11 GRAPHIC ex99-02_img04.jpg GRAPHIC 151797
12 GRAPHIC ex99-02_img05.jpg GRAPHIC 135542
13 GRAPHIC ex99-02_img06.jpg GRAPHIC 143903
14 GRAPHIC ex99-02_img07.jpg GRAPHIC 200585
15 GRAPHIC ex99-02_img08.jpg GRAPHIC 163002
16 GRAPHIC ex99-02_img09.jpg GRAPHIC 179246
17 GRAPHIC ex99-02_img10.jpg GRAPHIC 162328
18 GRAPHIC ex99-02_img11.jpg GRAPHIC 162987
19 GRAPHIC ex99-02_img12.jpg GRAPHIC 184344
20 GRAPHIC ex99-02_img13.jpg GRAPHIC 176944
21 GRAPHIC ex99-02_img14.jpg GRAPHIC 147612
22 GRAPHIC ex99-02_img15.jpg GRAPHIC 148320
23 GRAPHIC ex99-02_img16.jpg GRAPHIC 186500
24 GRAPHIC ex99-02_img17.jpg GRAPHIC 141292
25 GRAPHIC ex99-02_img18.jpg GRAPHIC 201509
26 GRAPHIC ex99-02_img19.jpg GRAPHIC 205796
27 GRAPHIC ex99-02_img20.jpg GRAPHIC 227293
28 GRAPHIC ex99-02_img21.jpg GRAPHIC 143508
29 GRAPHIC ex99-02_img22.jpg GRAPHIC 161041
30 GRAPHIC ex99-02_img23.jpg GRAPHIC 220468
31 GRAPHIC ex99-02_img24.jpg GRAPHIC 184205
32 GRAPHIC ex99-02_img25.jpg GRAPHIC 119955
33 GRAPHIC ex99-02_img26.jpg GRAPHIC 141664
34 GRAPHIC ex99-02_img27.jpg GRAPHIC 174100
35 GRAPHIC ex99-02_img28.jpg GRAPHIC 124334
36 GRAPHIC ex99-02_img29.jpg GRAPHIC 101413
37 GRAPHIC ex99-02_img30.jpg GRAPHIC 132697
38 GRAPHIC ex99-02_img31.jpg GRAPHIC 190171
39 GRAPHIC ex99-02_img32.jpg GRAPHIC 164849
40 GRAPHIC ex99-02_img33.jpg GRAPHIC 124021
41 GRAPHIC ex99-02_img34.jpg GRAPHIC 166202
42 GRAPHIC ex99-02_img35.jpg GRAPHIC 122605
43 GRAPHIC ex99-02_img36.jpg GRAPHIC 118781
44 GRAPHIC ex99-02_img37.jpg GRAPHIC 147664
45 GRAPHIC ex99-02_img38.jpg GRAPHIC 225706
46 GRAPHIC ex99-02_img39.jpg GRAPHIC 261045
47 GRAPHIC ex99-02_img40.jpg GRAPHIC 239246
48 GRAPHIC ex99-02_img41.jpg GRAPHIC 283747
  Complete submission text file 0001999371-24-006367.txt   10090626

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE tnxp-20240521.xsd EX-101.SCH 3024
5 XBRL LABEL FILE tnxp-20240521_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE tnxp-20240521_pre.xml EX-101.PRE 22365
60 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_8k-052124_htm.xml XML 3543
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 24966880
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)